WebMost cited. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L) WebIntroduction. Pancreatic cancer is a major cause of cancer-related mortality in western countries and it is projected to emerge as the second leading cause of cancer-related deaths in the United States by 2030. 1 Its prognosis is extremely poor, with a 5-year survival rate for all patients with pancreatic adenocarcinoma of approximately 6–8%. 2–5 The vast …
Frontiers Treatment options for recurrent platinum-resistant …
WebJ Clin Oncol 1986;4: 14-22. Crossref; Web of Science; ... J Clin Oncol 1989;7: 1602-1613. Crossref; Web of Science; Medline; Google Scholar. 21. Ramsey SD, Moinpour CM, Lovato LC, Grevstad PK ... WebMar 29, 2024 · J Clin Oncol. 2004;22:3860–3867. Sedrakyan A, van Der Meulen J, O'Byrne K, Prendiville J, Hill J, Treasure T. Postoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2004;128:414–419. Berghmans T, Paesmans M, Meert AP. Survival improvement in resectable non-small cell … dying light 2 launch date
Combined-Modality Therapy With Gemcitabine and …
WebJul 15, 2004 · 1 Gastric Surgery Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. [email protected] PMID: 15199090 DOI: 10.1200/JCO.2004.10.184 Abstract Purpose: Radical gastrectomy with regional lymphadenectomy is the only curative treatment option for gastric cancer. WebJ Clin Oncol. 2004;22(19):4010–4018. 15. Khatcheressian JL, Wolff AC, Smith TJ, et al. American society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. ... Cancer. 2006;107(11):2545–2551. 49. Aukema TS, Rutgers EJT, Vogel WV, et al. The role of FDG PET/CT in patients with ... WebMay 15, 2024 · J Clin Oncol. 2004; 22 (5):777–84. [Google Scholar] 8. Herbst RS, Giaccone G, Schiller JH, et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial – INTACT 2. J Clin Oncol. 2004; 22 (5):785–94. crystal reports runtime download arena